Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Washington University School of Medicine
Massachusetts General Hospital
Columbia University
University of Nebraska
OHSU Knight Cancer Institute
Herlev Hospital
M.D. Anderson Cancer Center
University of California, Davis
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
Stanford University
University of Arizona
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Stanford University
Stanford University
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
Stanford University
Fred Hutchinson Cancer Center
Chung-Ang University
Istituto Clinico Humanitas
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University Hospital, Antwerp
Herlev Hospital